Earnings History Data for MiMedx Group (MDXG) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

MiMedx Group

MiMedx is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. `Innovations in Regenerative Biomaterials` is the framework behind their mission to give physicians products and tissues to help the body heal itself. Their biomaterial platform technologies include AmnioFix and EpiFix, their tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through their donor program, a mother delivering via full-term Caesarean section birth can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. They process the human amniotic membrane utilizing their proprietary PURION Process, to produce a safe and effective implant.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
28-02-2024	AH		MDXG	MiMedx Group	954.00	0.04	0.08	0.00	MiMedx Group Non-GAAP EPS of $0.04 misses by $0.02, revenue of $87M beats by $1.85M [2/28/2024 4:07 PM]	8.19	-0.01 (-0.18%)	8.50	0.30 (3.66%)	3.08 - 9.27	1,711,989	700,000	1,277
MiMedx Group Non-GAAP EPS of $0.04 misses by $0.02, revenue of $87M beats by $1.85M [2/28/2024 4:07 PM]
30-10-2023	AH		MDXG	MiMedx Group, Inc	711.75	0.05	0.04	-0.09	MiMedx Group Non-GAAP EPS of $0.05 in-line, revenue of $81.71M beats by $3.77M [10/30/2023 4:25 PM]	6.55	0.23 (3.64%)	6.05	-0.27 (-4.27%)	2.43 - 8.60	664,642	480,000	90,283
MiMedx Group Non-GAAP EPS of $0.05 in-line, revenue of $81.71M beats by $3.77M [10/30/2023 4:25 PM]
01-08-2023	AH		MDXG	MiMedx Group, Inc	921.34	N/A	-0.02	-0.11	MiMedx Group GAAP EPS of $0.00 beats by $0.03, revenue of $81.3M beats by $6.47M [8/1/2023 4:19 PM]	7.70	-0.23 (-2.96%)	8.65	0.72 (9.08%)	2.43 - 8.60	1,397,805	820,000	6,091
MiMedx Group GAAP EPS of $0.00 beats by $0.03, revenue of $81.3M beats by $6.47M [8/1/2023 4:19 PM]
02-05-2023	AH	4:15 PM ET (May 2)	MDXG	MiMedx Group, Inc	416.40	-0.06	-0.09	-0.11	MiMedx Group GAAP EPS of -$0.06 beats by $0.03, revenue of $71.68M beats by $7.53M [5/2/2023 4:12 PM]	5.29	1.48 (38.98%)	4.46	0.65 (17.06%)	2.43 - 5.34	3,094,300	400,000	4,057
MiMedx Group GAAP EPS of -$0.06 beats by $0.03, revenue of $71.68M beats by $7.53M [5/2/2023 4:12 PM] MiMedx surges ~30% after Q1 revenue growth, cost controls drive down net loss [5/3/2023 12:21 PM]
28-02-2023	AH	4:15 PM ET (Feb 28)	MDXG	MiMedx Group, Inc	516.05	-0.02	-0.02	0.01	MiMedx Group GAAP EPS of -$0.02, revenue of $74.38M [2/28/2023 5:00 PM]	4.20	-0.61 (-12.79%)	5.00	0.19 (3.95%)	2.43 - 5.51	1,313,073	440,000	51,125
MiMedx Group GAAP EPS of -$0.02, revenue of $74.38M [2/28/2023 5:00 PM]
02-11-2022	AH	4:05 PM ET (Nov 2)	MDXG	MiMedx Group, Inc	336.28	-0.09	-0.09	-0.04	MiMedx Group GAAP EPS of -$0.09 in-line, revenue of $67.69M beats by $0.96M [11/2/2022 4:51 PM]	2.92	0.17 (5.98%)	2.76	0.0 (0.00%)	2.59 - 8.70	307,643	440,000	24,799
MiMedx Group GAAP EPS of -$0.09 in-line, revenue of $67.69M beats by $0.96M [11/2/2022 4:51 PM] MIMEDX Announces Third Quarter 2022 Operating and Financial Results [Nov-02-22 04:15PM] The past five years for MiMedx Group (NASDAQ:MDXG) investors has not been profitable [Nov-02-22 08:03AM]
02-08-2022	AH	4:30 PM ET (Aug 2)	MDXG	MiMedx Group, Inc	384.27	-0.11	-0.06	-0.03	MiMedx Group GAAP EPS of -$0.11 misses by $0.04, revenue of $66.88M beats by $1.81M [8/2/2022 5:01 PM]	3.70	0.26 (7.56%)	3.69	0.25 (7.27%)	3.04 - 15.99	696,089	320,000	501
MiMedx Group GAAP EPS of -$0.11 misses by $0.04, revenue of $66.88M beats by $1.81M [8/2/2022 5:01 PM] MIMEDX Announces Second Quarter 2022 Operating and Financial Results [Aug-02-22 04:05PM]
03-05-2022	AH	4:05 PM ET (May 3)	MDXG	MiMedx Group	460.00	-0.11	-0.10	0.00	MiMedx Group GAAP EPS of -$0.11 misses by $0.01, revenue of $58.89M beats by $4.79M [5/3/2022 4:39 PM]	4.38	0.30 (7.21%)	4.05	-0.04 (-0.98%)	3.75 - 15.99	375,708	530,000	3,011
MiMedx Group GAAP EPS of -$0.11 misses by $0.01, revenue of $58.89M beats by $4.79M [5/3/2022 4:39 PM] MIMEDX Announces First Quarter 2022 Operating and Financial Results [May-03-22 04:32PM]
28-02-2022	AH	4:50 PM ET (Feb 28)	MDXG	MiMedx Group, Inc	539.41	0.01	-0.03	-0.17	MiMedx Group GAAP EPS of $0.01 beats by $0.04, revenue of $67.29M beats by $3.6M [2/28/2022 4:24 PM]	5.02	-0.03 (-0.59%)	5.26	0.21 (4.16%)	4.12 - 15.99	327,595	540,000	28,048
MiMedx Group GAAP EPS of $0.01 beats by $0.04, revenue of $67.29M beats by $3.6M [2/28/2022 4:24 PM] MIMEDX Announces Fourth Quarter and Full Year 2021 Operating and Financial Results [Feb-28-22 04:06PM] MDXG: 2021 Results [Mar-01-22 06:47AM]
02-11-2021	AH	5:20 PM ET (Nov 2)	MDXG	MiMedx Group, Inc	764.62	-0.04	-0.08	-0.48	MiMedx Group EPS beats by $0.05, beats on revenue [11/2/2021 4:50 PM]	8.11	1.08 (15.36%)	7.20	0.17 (2.42%)	5.30 - 15.99	917,747	610,000	3,318
MiMedx Group EPS beats by $0.05, beats on revenue [11/2/2021 4:50 PM] MiMedx up 15% as net loss narrows in Q3 and beats Street expectations [11/3/2021 3:40 PM] Two New Studies Demonstrate in vitro Bioactivity Potential of Micronized Dehydrated Human Amnion Chorion Membrane (mdHACM) to Prevent Pathological Processes Underlying Osteoarthritis (OA) and Tendinopathy [Nov-01-21 08:30AM] MIMEDX to Participate at Upcoming Investor Conferences [Nov-02-21 08:00AM] MIMEDX Announces Third Quarter 2021 Operating and Financial Results [Nov-02-21 04:50PM]
03-08-2021	AH	5:00 PM ET (Aug 3)	MDXG	MiMedx Group, Inc	1,370	-0.03	-0.07	-0.08	MiMedx Group EPS beats by $0.04, beats on revenue [8/3/2021 5:27 PM]	11.89	-0.66 (-5.26%)	11.89	0.0 (0.00%)	5.32 - 13.02	535,412	460,000	8,078
MiMedx Group EPS beats by $0.04, beats on revenue [8/3/2021 5:27 PM] MIMEDX Announces Second Quarter 2021 Operating and Financial Results [Aug-03-21 05:22PM]
28-04-2021	AH	5:30 PM ET (Apr 28)	MDXG	MiMedx Group, Inc	1,180	-0.09	-0.19	-0.04	MiMedx Group EPS beats by $0.10, misses on revenue [4/28/2021 5:04 PM]	10.19	-0.52 (-4.90%)	10.20	-0.51 (-4.76%)	3.30 - 12.87	1,157,463	510,000	12,558
MiMedx Group EPS beats by $0.10, misses on revenue [4/28/2021 5:04 PM] MiMedx Welcomes Dirk Stevens, Ph.D., as Senior Vice President, Quality Assurance and Regulatory Affairs [Apr-28-21 10:21AM] MiMedx Announces First Quarter 2021 Financial and Operating Results [Apr-28-21 05:00PM] MiMedx Group, Inc. to Host Earnings Call [Apr-29-21 06:30AM]
08-03-2021	AH	4:05 PM ET (Mar 8)	MDXG	MiMedx Group, Inc	1,120	-0.17	-0.05	-0.34	MiMedx Group EPS misses by $0.12, beats on revenue [3/8/2021 5:41 PM]	8.96	-0.96 (-9.68%)	9.70	-0.22 (-2.22%)	2.95 - 11.44	1,045,064	572,069	3,520
MiMedx Group EPS misses by $0.12, beats on revenue [3/8/2021 5:41 PM] MiMedx Group, Inc. to Host Earnings Call [Mar-09-21 06:30AM] MiMedx Announces Appointment of Phyllis Gardner, M.D. to Board of Directors [Mar-08-21 05:33PM] MiMedx Announces Fourth Quarter and Full Year 2020 Financial and Operating Results [Mar-08-21 05:32PM]
04-11-2020	AH	After the close (Nov 4)	MDXG	MiMedx Group, Inc	690.64	-0.48	0.00	0.00	MiMedx Group reports Q3 results [11/4/2020 4:20 PM]	6.72	-0.51 (-7.05%)	7.59	0.36 (4.98%)	2.95 - 7.95	447,014	318,907	266